235 related articles for article (PubMed ID: 37109756)
1. Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study.
Lukjanoviča K; Šlēziņa I; Dāvidsone Z; Šantere R; Budarina K; Staņēviča V
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109756
[No Abstract] [Full Text] [Related]
2. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
3. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
5. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.
Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A
Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234
[TBL] [Abstract][Full Text] [Related]
7. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
[No Abstract] [Full Text] [Related]
8. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
Yokota S; Itoh Y; Morio T; Sumitomo N; Daimaru K; Minota S
J Rheumatol; 2015 Apr; 42(4):712-22. PubMed ID: 25684767
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
11. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment.
Sukharomana M; Udomittipong K; Ruangchira-Urai R; Charuvanij S
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):172-176. PubMed ID: 31837211
[TBL] [Abstract][Full Text] [Related]
13. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert GS; Yasin S; Carey B; Chalk C; Do T; Schapiro AH; Husami A; Watts A; Brunner HI; Huggins J; Mellins ED; Morgan EM; Ting T; Trapnell BC; Wikenheiser-Brokamp KA; Towe C; Grom AA
Arthritis Rheumatol; 2019 Nov; 71(11):1943-1954. PubMed ID: 31379071
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience.
Jelušić M; Kronja M; Frković M; Sršen S; Huljev Frković S; Štekić Novački K
Acta Clin Croat; 2018 Jun; 57(2):307-311. PubMed ID: 30431724
[TBL] [Abstract][Full Text] [Related]
15. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O
Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940
[TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
[TBL] [Abstract][Full Text] [Related]
17. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management.
Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J
Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594
[TBL] [Abstract][Full Text] [Related]
18. Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis-associated refractory macrophage activation syndrome.
Wu J; Sun L; Tang X; Zheng Q; Guo L; Xu L; Li Y; Lu M
Mod Rheumatol; 2022 Oct; 32(6):1114-1121. PubMed ID: 34971386
[TBL] [Abstract][Full Text] [Related]
19. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
[TBL] [Abstract][Full Text] [Related]
20. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]